Vir Biotechnology has partnered with Astellas Pharma to develop VIR-5500, its masked PSMA-targeting T-cell engager for ...

Incyte Corporation is a profitable, cash-generating biotech with a robust pipeline and a core revenue driver in Jakafi. Read ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

The United States and China are engaged in a competition that will shape far more than the future of medicine.

Recent advancements in biotechnology have immense potential to help address many global problems; climate change, an aging society, food security, energy security, and infectious diseases.

Biotechnology has long relied on a handful of model microorganisms, such as Escherichia coli and Saccharomyces cerevisiae, whose genetics and physiology are ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

The iShares Global Healthcare ETF(NYSEMKT:IXJ) provides broad, established exposure to global healthcare giants, while the Invesco Nasdaq Biotechnology ETF(NASDAQ:IBBQ) offers a lower-cost ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Timothy Coughlin to its Board of Directors and as Chair of the Audit Committee, effective June 9, 2026. “We are pleased to ...

Cellyan Biotechnology Co. Ltd HKPD shares remained under pressure after the company disclosed that it received an additional ...